Contact: Alex Smith
212.367.3892
asmith@jgordonassociates.com
Yivsam Azgad
011.972.8.934.3852
Yivsam.Azgad@weizmann.ac.il
EMBARGOED FOR RELEASE
Wednesday, April 28, 2004, 1PM EST
BIOLOGICAL COMPUTER DIAGNOSES CANCER
AND PRODUCES DRUG – IN A TEST TUBE
Weizmann
Institute scientist’s vision:
Microscopic
computers will function inside living tissues,
performing
diagnosis and administering treatment.
Rehovot,
Israel — April 28, 2004 — The
world’s smallest computer (around a trillion can fit in a drop of water) might
one day go on record again as the tiniest medical kit. Made entirely of
biological molecules, this computer was successfully programmed to identify –
in a test tube – changes in the balance of molecules in the body that indicate
the presence of certain cancers, to diagnose the type of cancer, and to react
by producing a drug molecule to fight the cancer cells.
The Weizmann Institute of Science team that developed
the computer published these results today in Nature. Headed by Prof.
Ehud Shapiro of the Departments of Computer Sciences and Applied Mathematics,
and Biological Chemistry, the team included research students Yaakov Benenson,
Binyamin Gil, Uri Ben-Dor and Dr. Rivka Adar. Shapiro presented the team’s
findings today at the Brussels symposium, “Life, a Nobel Story,” in which Nobel
Laureates and others addressed the future of the life sciences.
As in previous biological computers produced in
Shapiro’s lab, input, output and “software” are all composed of DNA, the
material of genes, while DNA-manipulating enzymes are used as “hardware.” The
newest version’s input apparatus is designed to assess concentrations of
specific RNA molecules, which may be overproduced or under produced, depending
on the type of cancer. Using pre-programmed medical knowledge, the computer
then makes its diagnosis based on the detected RNA levels. In response to a
cancer diagnosis, the output unit of the computer can initiate the controlled
release of a single-stranded DNA molecule that is known to interfere with the
cancer cell’s activities, causing it to self-destruct.
-more-
Weizmann
2-2-2-2-2
In one series of test-tube experiments, the team
programmed the computer to identify RNA molecules that indicate the presence of
prostate cancer and, following a correct diagnosis, to release the short DNA
strands designed to kill cancer cells. Similarly, they were able to identify,
in the test tube, the signs of one form of lung cancer. One day in the future,
they hope to create a “doctor in a cell”, which will be able to operate inside
a living body, spot disease and apply the necessary treatment before external
symptoms even appear.
The original version of the biomolecular computer
(also created in a test tube) capable of performing simple mathematical
calculations, was introduced by Shapiro and colleagues in 2001. An improved system, which uses its input DNA
molecule as its sole source of energy, was reported in 2003 and was listed in
the 2004 Guinness Book of World Records as the smallest biological computing
device.
Shapiro: “It is clear that the road to realizing our
vision is a long one; it may take decades before such a system operating inside
the human body becomes reality. Nevertheless, only two years ago we predicted
that it would take another 10 years to reach the point we have reached today.”
Prof. Ehud Shapiro's
research is supported by the M.D. Moross Institute for Cancer Research, the
Samuel R. Dweck Foundation, the Dolfi and Lola Ebner Center for Biomedical
Research, the Benjamin and Seema Pulier Charitable Foundation, and the Robert
Rees Fund for Applied Research.
The Weizmann
Institute of Science in Rehovot, Israel, is one of the world's top-ranking
multidisciplinary research institutions. Noted for its wide-ranging exploration
of the natural and exact sciences, the Institute is home to 2,500 scientists,
students, technicians and supporting staff. Institute research efforts include
the search for new ways of fighting disease and hunger, examining leading
questions in mathematics and computer science, probing the physics of matter
and the universe, creating novel materials and developing new strategies for
protecting the environment.
###